FDA Import Refusal SCS-2174271-9/10002/1 — Merz Pharma GmbH & Co., KGaA
The FDA refused shipment SCS-2174271-9/10002/1 from Merz Pharma GmbH & Co., KGaA (Germany) on Jan 22, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charges: 118,3280,472,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 22, 2026
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 58PCZ05 ONABOTULINUMTOXINA
- Charges
- 118,3280,472,75